Using this technology we can have much broader protection, which is important because the virus is always changing.

Bird flu is something we should be prepared for, but even if a pandemic never happens, everything we learn now from this vaccine can be applied to vaccines for other emerging infectious diseases.

This is a very potent vaccine. The results of this animal trial are very promising.

Eventually we will need to partner with a company for large-scale production of vaccine.

That means there is a lot of chance of getting cross-reactivity.

We generated the portion that we think was important for immunity. We never manipulated the actual H5N1 virus ourselves, so it is safe to generate this kind of vaccine.

Bird flu may likely become the next pandemic, and this vaccine is worth investigating further.

This is a very potent vaccine. It took roughly about 30 days to make the vaccine from when we received the sequence information from CDC in Atlanta.